|
Note 6 - Share Capital (Details)
|
0 Months Ended | 9 Months Ended | 12 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 0 Months Ended | 0 Months Ended | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 23, 2014
USD ($)
|
Sep. 17, 2014
USD ($)
|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2013
USD ($)
|
Dec. 31, 2012
USD ($)
|
Dec. 31, 2014
CAD
|
Sep. 18, 2014
|
Jun. 06, 2014
|
Jun. 05, 2014
|
Jun. 30, 2013
|
Feb. 28, 2011
|
Dec. 31, 2014
Class UA preferred Stock [Member]
|
Dec. 31, 2013
Class UA preferred Stock [Member]
|
Dec. 31, 2014
Series A Convertible Preferred Stock [Member]
USD ($)
|
Sep. 22, 2014
Series A Convertible Preferred Stock [Member]
USD ($)
|
Dec. 31, 2013
Series A Convertible Preferred Stock [Member]
USD ($)
|
Feb. 11, 2015
Series B Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Subsequent Event [Member]
Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member]
|
Feb. 11, 2015
Series B Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Subsequent Event [Member]
USD ($)
|
Feb. 11, 2015
Series B Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Subsequent Event [Member]
USD ($)
|
Feb. 11, 2015
Series B Convertible Preferred Stock [Member]
Subsequent Event [Member]
Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member]
|
Dec. 31, 2014
Common Class A [Member]
USD ($)
|
Dec. 31, 2013
Common Class A [Member]
USD ($)
|
Sep. 23, 2014
Series A Preferred Stock [Member]
USD ($)
|
Dec. 31, 2014
September 2010 Warrants [Member]
USD ($)
|
Dec. 31, 2013
September 2010 Warrants [Member]
USD ($)
|
May 26, 2014
May 2009 Warrants [Member]
|
Dec. 31, 2013
May 2009 Warrants [Member]
USD ($)
|
Feb. 11, 2015
Common Stock [Member]
Subsequent Event [Member]
Exchange Agreement With Certain Affiliates of Biotechnology Value Fund [Member]
|
Feb. 11, 2015
Common Stock [Member]
Subsequent Event [Member]
USD ($)
|
Feb. 11, 2015
Common Stock [Member]
Subsequent Event [Member]
USD ($)
|
Sep. 23, 2014
Common Stock [Member]
USD ($)
|
Dec. 31, 2014
Common Stock [Member]
|
Dec. 31, 2013
Common Stock [Member]
|
Dec. 31, 2012
Common Stock [Member]
|
Sep. 23, 2014
Convertible Preferred Stock [Member]
USD ($)
|
Feb. 18, 2015
Underwriter Options [Member]
Subsequent Event [Member]
USD ($)
|
Feb. 11, 2015
Underwriter Options [Member]
Subsequent Event [Member]
|
Feb. 18, 2015
Underwriter Options [Member]
Subsequent Event [Member]
USD ($)
|
Feb. 18, 2015
Subsequent Event [Member]
USD ($)
|
Feb. 03, 2012
At The Market Equity Offering Program [Member]
USD ($)
|
Sep. 23, 2014
Additional Shares to Purchase New Shares [Member]
|
Sep. 23, 2014
September 2014 Offerings [Member]
USD ($)
|
Jun. 04, 2013
Biotechnology Value Fund, L.P. and Other Affiliates of BVF Partners L.P. [Member]
USD ($)
|
Jun. 04, 2013
Biotechnology Value Fund, L.P. and Other Affiliates of BVF Partners L.P. [Member]
USD ($)
|
|
| Note 6 - Share Capital (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 12,500 | 12,500 | 10,000,000 | 10,000 | 10,000,000 | |||||||||||||||||||||||||||||||||||||
| Preferred Stock, Shares Issued | 10,000 | 0 | 12,500 | 12,500 | 10,000 | 10,000 | 10,000 | 1,333 | 10,000 | |||||||||||||||||||||||||||||||||||
| Preferred Stock, Shares Outstanding | 10,000 | 0 | 12,500 | 12,500 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||
| Class UA Preferred Stock Liquidation Preference Percentage | 20.00% | |||||||||||||||||||||||||||||||||||||||||||
| Class UA Preferred Stock Liquidation Preference (in Dollars) | 100 | |||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||||||||||||||||||||
| Convertible Preferred Stock to Be Converted | 1,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||
| Maximum Ownership Percentage Of Common Shares Outstanding Post Conversion | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 0.0001 | |||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period, Shares, New Issues | 10,000,000 | 8,364,379 | 4,000 | 4,000 | 13,500,000 | 11,517,478 | 13,346,901 | 13,512,500 | 1,500,000 | |||||||||||||||||||||||||||||||||||
| Share Price (in Dollars per share) | $ 1.90 | $ 1.90 | $ 1.76 | $ 1.76 | $ 1.50 | $ 1.50 | ||||||||||||||||||||||||||||||||||||||
| Proceeds From Issuance of Common Stock Gross (in Dollars) | 20,000,000 | 16,600,000 | 20,000,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||
| Convertible Preferred Stock, Price Per Share (in Dollars per share) | $ 1,500 | $ 2,000 | ||||||||||||||||||||||||||||||||||||||||||
| Proceeds From Issuance of Convertible Preferred Stock Gross (in Dollars) | 2,000,000 | 20,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| Option Expiration Period | 30 days | 30 days | ||||||||||||||||||||||||||||||||||||||||||
| Additional Shares Granted, Gross | 2,025,000 | |||||||||||||||||||||||||||||||||||||||||||
| Additional Shares Granted, Net | 1,199,660 | |||||||||||||||||||||||||||||||||||||||||||
| Proceeds from Issuance or Sale of Equity (in Dollars) | 16,100,000 | 1,700,000 | 22,400,000 | 40,200,000 | 9,900,000 | |||||||||||||||||||||||||||||||||||||||
| Proceeds From Issuance or Sale of Equity Gross (in Dollars) | 24,000,000 | 43,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| Payments of Stock Issuance Costs (in Dollars) | 500,000 | 1,600,000 | 2,800,000 | |||||||||||||||||||||||||||||||||||||||||
| Common Stock Exchanged for Shares of Convertible Preferred Stock | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| Common Stock, Shares Authorized | 200,000,000 | 100,000,000 | 200,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||||||||||||||||||||||
| Common Stock, Value, Issued (in Dollars) | 353,856,000 | 353,854,000 | 9,160 | 7,067 | ||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,000,000 | 5,000,000 | 48,701 | 3,182,147 | ||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right, Number of Warrants Expired in Period | (2,691,242) | 2,691,242 | ||||||||||||||||||||||||||||||||||||||||||
| Number Of Underwriting Agreements | 2 | |||||||||||||||||||||||||||||||||||||||||||
| Sale of Stock, Price Per Share (in Dollars per share) | $ 2.00 | |||||||||||||||||||||||||||||||||||||||||||
| Proceeds from Issuance of Common Stock (in Dollars) | 21,668,000 | 26,069,000 | 50,466,000 | 21,600,000 | ||||||||||||||||||||||||||||||||||||||||
| Proceeds from Issuance of Convertible Preferred Stock (in Dollars) | 18,693,000 | 18,600,000 | ||||||||||||||||||||||||||||||||||||||||||
| Direct Offering, Units Issued | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| Direct Offering, Shares Per Unit Issued | 1 | |||||||||||||||||||||||||||||||||||||||||||
| Direct Offering Warrants Per Unit Issued | 1 | |||||||||||||||||||||||||||||||||||||||||||
| Sale Price of Common Stock and Warrants Per Unit (in Dollars per share) | $ 2.00 | |||||||||||||||||||||||||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 4.24 | $ 4.24 | $ 3.74 | $ 5.00 | ||||||||||||||||||||||||||||||||||||||||
| Aggregate Gross Sales Proceeds Under Sales Agreement (in Dollars) | $ 50,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| Sales Agreement Compensation Percentage | 3.00% | |||||||||||||||||||||||||||||||||||||||||||